BUSINESS
Kyowa Kirin Debuts Crysvita Prefilled Syringe and Lumicef Auto-Injector in Japan
Kyowa Kirin said on November 19 that it has rolled out two new formulations in Japan: a prefilled syringe version of its anti-FGF23 antibody Crysvita (burosumab) and a pen-type auto-injector for its anti-IL-17 receptor A antibody Lumicef (brodalumab). Crysvita was…
To read the full story
BUSINESS
- Drug Makers Keep New Grad Hiring Largely Flat as Sales Rep Hiring Picks Up
April 6, 2026
- Japan Drug Makers Vetting Impact as Trump Unveils Tariff Details
April 6, 2026
- Expert Highlights Subcutaneous Benefits of Rybrofaz in Lung Cancer
April 6, 2026
- NEC Bio, Transgene Strike Licensing Deal for Cancer Vaccine
April 6, 2026
- Takeda Says US Revamp “Not Simply Workforce Reduction” as 634 Roles Impacted
April 3, 2026
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…





